共 33 条
[1]
Hautmann RE(2012)Radical cystectomy for urothelial carcinoma of the bladder without neoadjuvant or adjuvant therapy: long-term results in 1100 patients Eur Urol 61 1039-1047
[2]
de Petriconi RC(2010)Lessons learned from 1,000 neobladders: the 90-day complication rate J Urol 184 990-994
[3]
Pfeiffer C(2012)Long-term outcomes of selective bladder preservation by combined-modality therapy for invasive bladder cancer: the MGH experience Eur Urol 61 705-711
[4]
Hautmann RE(2011)15-year survival rates after transurethral resection and radiochemotherapy or radiation in bladder cancer treatment Anticancer Res 31 985-990
[5]
de Petriconi RC(2014)Critical analysis of bladder sparing with trimodal therapy in muscle-invasive bladder cancer: a systematic review Eur Urol 66 120-137
[6]
Volkmer BG(2014)Long-term outcomes in patients with muscle-invasive bladder cancer after selective bladder-preserving combined-modality therapy: a pooled analysis of Radiation Therapy Oncology Group protocols 8802, 8903, 9506, 9706, 9906, and 0233 J Clin Oncol 32 3801-3809
[7]
Efstathiou JA(2010)Impact of routine second transurethral resection on the long-term outcome of patients with newly diagnosed pT1 urothelial carcinoma with respect to recurrence, progression rate, and disease-specific survival: a prospective randomised clinical trial Eur Urol 58 185-190
[8]
Spiegel DY(2013)EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013 Eur Urol 64 639-653
[9]
Shipley WU(2001)Transurethral resection of muscle-invasive bladder cancer: 10-year outcome J Clin Oncol 19 89-93
[10]
Krause FS(2002)Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results J Clin Oncol 20 3061-3071